Molecular Analysis Of Bladder Cancer
Sponsor
Lahey Clinic (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00871754
Collaborator
(none)
5,000
1
452
11.1
Study Details
Study Description
Brief Summary
This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
5000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Molecular Analysis Of Bladder Cancer
Study Start Date
:
Apr 1, 1988
Anticipated Primary Completion Date
:
Dec 1, 2025
Anticipated Study Completion Date
:
Dec 1, 2025
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Bladder cancer
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Lahey Clinic | Burlington | Massachusetts | United States | 01805 |
Sponsors and Collaborators
- Lahey Clinic
Investigators
- Principal Investigator: Kim Reiger-Christ, PhD, Lahey Clinic
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Linda Topjian,
study coordinator,
Lahey Clinic
ClinicalTrials.gov Identifier:
NCT00871754
Other Study ID Numbers:
- 88-009A
First Posted:
Mar 30, 2009
Last Update Posted:
Jan 19, 2022
Last Verified:
Jan 1, 2022
Keywords provided by Linda Topjian,
study coordinator,
Lahey Clinic
Additional relevant MeSH terms: